Post on 14-Apr-2017
EUROPEAN AFFAIRS &
GRANTS OFFICE Helping you to successfully obtain
international funding
& manage your international grants
21/02/2017
Who we are
21/02/2017 2
European Affairs & Grants Office
Director, Fabien Calvo
Espace Maurice Tubiana
Coordination & project
management
Consortium Task Forces
o Data sharing platform
o Immunotherapy
o Clinical imaging
o Patient genomics
o Clinical Trials
o Education & Training
GR, DKFZ, NKI,
KI, VHIO, CCC
EIT grant
Success stories
21/02/2017 3
European Affairs Office’s experience
− 15 years’ experience
− Managing over 29* European FP7 grants
*16 in health
− 12.2 million € total amount FP7
− Coordination as project leader - totaling over 8 million €
− Experience writing successfully funded projects
Experience as grant reviewer
Future success:
Helping you to succeed in getting more international projects funded
More EU funding than ever before
21/02/2017 5
• Almost €77 billion from 2014 to 2020 (up from 50.5 billion in FP7)
• More funding for basic research (ERC grants)
• More funding for SMEs (small-to-medium sized enterprises)
European Commission’s focus has shifted
21/02/2017 6
* total budget in societal
challenges
Unified program Emphasis on societal challenges
From research to market
SME participation should increase to 20%* (up from 15%)
Focus on “technology readiness levels” TRLs
Impact & gender parity SME participation & gender balance can be used in
“tie-break” situations
More focus on impact of research
Emphasis on jobs created
Simplified rules
21/02/2017 8
3 elements of evaluation & review*
* For ERC grants – the only criteria is “excellence”
Time to grant is reduced
Your research project starts sooner (5 months evaluation + 3 months negotiation)
Excellence Impact Implementation
Simplified rules
21/02/2017 9
One project – one funding rate simplified budgets
overheads 25%
Less paperwork
No timesheets for full time employees (pending internally)
Standard reporting period = 18 months (some exceptions)
EC wants fewer deliverables/milestones (less work for everyone)
Reports must be submitted before the deliverable deadline
Fewer, better targeted controls & audits
How our office can help
21/02/2017 11
Which calls will be open and when are the deadlines?
Do I (or we) meet the call requirements?
Can I get help editing the scientific English in my final application?
Is our proposed project a good match to the call text?
Do I/we need to include other partners (ex. small business)?
What if I decide to coordinate the project—how much extra work is
involved?
before you start writing
How our office can help
21/02/2017 12
Before grant submission
Budget preparation & coordination with partners
Scientific English editing
Overview of other GR projects
During grant submission
Grant agreement negotiation (before the grant starts)
Amendments – change of partners
Reporting
Financial forms; verify reports meet requirements
Final report & grant wrap-up
European Commission’s unified view
21/02/2017 14
Innovative Medicines Initiative (IMI)
Industrial
Leadership
Societal
Challenges
Excellent
Science
European Commission’s unified view
21/02/2017 15
• (LEIT) nano &
biotechnology
• Venture capital for
research
• Small-to-medium
sized enterprises
• Health
• Food security
• Climate &
environment
• ERCs
• (FET) radically new
future technologies
• Marie Curie
fellowships,
training, staff
exchange
• Infrastructures, ie.
ECRIN
Industrial Leadership Societal Challenges Excellent Science
- EIT health
- Euratom
- IMI innovative medicine
bottom-up
funded projects
Of potential interest
21/02/2017 16
RIA - Research and Innovation Action
Lead to new knowledge, new or improved technology
IA - Innovation Action
Focus on closer-to-the-market activities
prototyping, scaling-up, to produce new or improved products or
services
Ideal for ideas that could generate spin-off company
Decoding H2020 funding opportunities—an overview
CSA - Coordination and Support Action
Coordination and networking of research & innovation projects, programs
and policies
- standardization, dissemination, communication, policy dialogues…
PPP – Public Private Partnership
Links Europe’s industry (both large & small) with researchers, academia +
the European Commission to cooperate in data research and innovation
€ € €
21/02/2017 17
- 200K up to 30 million €
- Project length is generally 3 to 5 years
- International - 3 different EU member partners
- Interdisciplinary
- Inter-sector (SMEs, private sector, hospitals, patient orgs)
- Gender balanced/gender parity
- SME participation & gender parity can be used to tie break
Keys to success—research & innovation actions
Societal Challenges
Health Decoding H2020 funding opportunities:
21/02/2017 18
PM-20-2017: Methods research for improved health economic evaluation
PM-19-2017: PPI for uptake of standards for the exchange of digitalised
healthcare records
PM-17-2017: Personalised computer models and in-silico systems for
well-being
PM-16-2017: In-silico trials for developing and assessing biomedical
products
PM-11-2016-2017: Clinical research on regenerative medicine
PM-03-2017: Diagnostic characterisation of rare diseases
HCO-08-2017: Actions to bridge the divide in European health research
and innovation
HCO-08-2017: Actions to bridge the divide in European health research
and innovation
Societal Challenges
Health Decoding H2020 funding opportunities
Decoding H2020 funding opportunities:
(TRL) Technology Readiness Levels
21/02/2017 19
Industry
Society
TRL 9
TRL 8
TRL 7
TRL 6
TRL 5
TRL 4
TRL 3
TRL 2
TRL 1
EIT
Marie
Curie fellowships
FET
ERC
RIA Research &
innovation
CSA Coordination
& support
PPP Public-
private
partnership
21/02/2017 20
TRL 9
TRL 8
TRL 7
TRL 6
TRL 5
TRL 4
TRL 3
TRL 2
TRL 1
Product complete
Product
development
Technology
demonstration
Technology development
Laboratory
research
Basic
research
Approval
Basic Research
Phase III Trials
Phase II Trials
Phase I Trials
Candidates selected
Target identification
Decoding H2020 funding opportunities:
(TRL) Technology Readiness Levels
21/02/2017 21
Topics 2016 – 2017
Big Data
Large Scale Pilot actions in sectors best benefitting
from data-driven innovation
Internet of things
Creating “smart environments”
iPhone apps to measure health
(LEIT) Leadership in Enabling & Industrial
Technologies Industrial
Leadership
21/02/2017 22
- Funding: European Federation of Pharmaceutical
Industries + EU commission
- Topics developed by pharma
- Cancer Core Europe members on Scientific
Committee
- Developing topics include:
Sharing of patient data within EU
Immuno-oncology
- 2-stage Submission process
- EIT health
- Euratom
- IMI innovative medicine
21/02/2017 23
- Gustave Roussy has experience:
- Creation of a pan-European
paediatric clinical trials network
- EIT health
- Euratom
- IMI innovative medicine
21/02/2017 24
Excellent science from the bottom-up
In brief – you decide
which scientific questions
are of interest
(no pre-scripted topics)
Excellent Science ERC, FET
Marie Curie
21/02/2017 25
FET - Future and Emerging Technologies
FET Open (“open” = bottom-up)
7 of 24 funded projects were health-related
- MRG-GRammar …make a significant breakthrough in deciphering and
evolving the regulatory code.
- CONQUER will explore a fundamentally new contrast mechanism with
the potential to push magnetic resonance imaging (MRI) far beyond its
limits…
FET Proactive
Biotech for better life:
- Intra- and inter-cell biotechnologies
- New computing paradigms and their technologies
Excellent Science ERC, FET
Marie Curie
21/02/2017 26
Excellent science from the bottom-up
ERC – frontier research
− Researchers at all career stages can apply for funding
− Looking for projects at the frontiers of science that are interdisciplinary,
pioneering, address new & emerging fields, introduce unconventional,
innovative approaches
− The single peer review criteria is excellence
Starting Fall 2017
Consolidator 9 Feb 2017
Advanced 31 Aug 2017
Proof-of-concept 25 Apr 2017 / 05 Sept
Excellent Science ERC, FET
Marie Curie
21/02/2017 27
Excellent science from the bottom-up
ERC evaluation & peer review
for Starting, Consolidator and Advanced Grants
− Single-stage submission, two-stage evaluation
Step 1: 5-page synopsis, CV & track record
Step 2: 15-page full proposal description (plus what’s above)
− Interview with PI is part step 2 evaluation for Starting and Consolidator
(not for Advanced Grants)
− PI must choose the panel—up to 15 leading researchers
− For interdisciplinary proposals: can choose primary and secondary
panel
Excellent Science ERC, FET
Marie Curie
21/02/2017 28
Excellent science from the bottom-up
Marie Curie actions
RISE – research and innovation staff exchange
− 4 year program, 4-6 organizations
− Minimum 3 participants in 3 different countries and either:
o Include a Third Country (ie. USA, Israel, Canada)
o Or 1 academic & 1 non-academic
− Activities: skills acquisition, workshops, conferences, career development
(ITN) Innovative Training Networks (PhD students)
− European Training Network
> min. 3 partners in & outside academia, 3 EU countries
− European Industrial Doctorates
> 1 academic, 1 non-academic, in 2 EU countries
− European Joint Doctorates
> min. 3 academics create network to deliver joint degrees
> to promote international, intersectoral and multi/interdisciplinary collaboration
Excellent Science ERC, FET
Marie Curie
21/02/2017 29
Excellent science from the bottom-up
Individual Fellowships*
*Researchers must not have lived, worked, or studied in the host
institute’s country in the past 3 years*
European
− 12 to 24 months, from any country to Europe
− Help to reintegrate researchers coming back to Europe
Global
− 12 to 24 months plus return phase
− Secondments from Europe to Third Country
− Mandatory 12 month return phase in Europe (not subject to mobility
rule)
− Special considerations for “Career Restart” and “Reintegration”
Excellent Science ERC, FET
Marie Curie
Evaluation &
negotiaton
Preparation
phase
Project lifetime
Ap
plic
atio
n
Ca
ll F
or
Pro
po
sa
l
Ongoin
g M
anagem
ent
Eva
lua
tio
n
Timeline
(months)
Pre
-ca
ll
0 5-8
6 to 12 mo. before
submission
Su
bm
issio
n
Co
ntr
act N
eg
otia
tio
n
Sig
n G
ran
t A
gre
em
en
t
Pro
jec
t S
tart
Pro
ject C
lose
-out
5 8 0-60
P
eriodic
report
ing
18, 36, final
Grants office can help during entire project lifetime
21/02/2017 30
Evaluation criteria
21/02/2017 31
EXCELLENCE:
‒ trans-disciplinary
‒ proposed work is ambitious, innovation potential, beyond state of the art (e.g. ground-breaking objectives, novel concepts and approaches)
IMPACT:
‒ enhancing innovation
‒ developing innovations meeting the needs of markets;
‒ environmental and socially important impact;
‒ exploit and disseminate project results, manage research data
IMPLEMENTATION:
‒ coherence and effectiveness of the work plan
‒ appropriate allocation of tasks and resources
‒ complementarity of the participants within the consortium
‒ appropriate management, including risk and innovation management
Thank you!
Director European Affairs
& CSO Cancer Core Europe
Fabien Calvo
Fabien.Calvo@gustaveroussy.fr
Scientific Officer
Alysia vandenBerg
Alysia.vandenberg@gustaveroussy.fr
Program Manager
Arnauld Forest
Arnauld.FOREST@gustaveroussy.fr
Project Manager
Giovanni Scoazec
giovanni.scoazec@gustaveroussy.fr